{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T18:38:26Z","timestamp":1774723106808,"version":"3.50.1"},"publisher-location":"Chichester, UK","reference-count":64,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd008040.pub2","type":"reference-entry","created":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T18:53:34Z","timestamp":1288637614000},"source":"Crossref","is-referenced-by-count":16,"title":["Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults"],"prefix":"10.1002","author":[{"given":"Sheena","family":"Derry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R Andrew","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry J","family":"McQuay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,11,10]]},"reference":[{"issue":"10","key":"10.1002\/14651858.CD008040.pub2-BIB1|cit1","first-page":"388","article-title":"Double-blind controlled study of paramax in the acute treatment of common and classical migraine","volume":"39","author":"Dexter","year":"1985","journal-title":"British Journal of Clinical Practice"},{"issue":"3","key":"10.1002\/14651858.CD008040.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1185\/0300799009117025","article-title":"Comparison of a fixed combination of domperidone and paracetamol (Domperamol) with sumatriptan 50 mg in moderate to severe migraine: a randomised UK primary care study","volume":"16","author":"Dowson","year":"2000","journal-title":"Current Medical Research and Opinion"},{"issue":"6","key":"10.1002\/14651858.CD008040.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1526-4610.2007.01053.x","article-title":"Efficacy and tolerability of coadministration of rizatriptan and acetaminophen vs rizatriptan or acetaminophen alone for acute migraine treatment","volume":"48","author":"Freitag","year":"2008","journal-title":"Headache"},{"key":"10.1002\/14651858.CD008040.pub2-BIB4|cit4","unstructured":"A double-blind, general practice study to compare GR43175 with paracetamol and metoclopramide in the acute treatment of migraine (Original protocol). 1992 Available at: www.gsk-clinicalstudyregister.com\/"},{"key":"10.1002\/14651858.CD008040.pub2-BIB5|cit5","unstructured":"A double-blind, general practice study to compare GR43175 with paracetamol and metoclopramide in the acute treatment of migraine (Amended protocol). 1992 Available at: www.gsk-clinicalstudyregister.com\/"},{"issue":"11","key":"10.1002\/14651858.CD008040.pub2-BIB6|cit6","first-page":"642","article-title":"Treatment of migraine attacks: combination of dihydroergotamine tartrate and paracetamol in comparison with individual drugs and placebo","volume":"88","author":"Hoernecke","year":"1993","journal-title":"Medizinische Klinik (Munich)"},{"issue":"22","key":"10.1002\/14651858.CD008040.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1001\/archinte.160.22.3486","article-title":"Efficacy and safety of acetaminophenin the treatment of migraine. Results of a randomized, double-blind, placebo-controlled, population-based study","volume":"160","author":"Lipton","year":"2000","journal-title":"Archives of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD008040.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1046\/j.1468-2982.1993.1302124.x","article-title":"Domperidone plus paracetamol in the treatment of migraine","volume":"13","author":"MacGregor","year":"1993","journal-title":"Cephalalgia"},{"issue":"38","key":"10.1002\/14651858.CD008040.pub2-BIB9|cit9","first-page":"2436","article-title":"Tolfenamic acid versus paracetamol in migraine attacks. A double-blind study in general practice","volume":"151","author":"N\u00f8rrelund","year":"1989","journal-title":"Ugeskrift for Laeger"},{"issue":"5","key":"10.1002\/14651858.CD008040.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1526-4610.2010.01638.x","article-title":"A randomized, placebo-controlled trial of acetaminophen for treatment of migraine headache","volume":"50","author":"Prior","year":"2010","journal-title":"Headache"},{"issue":"4","key":"10.1002\/14651858.CD008040.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1526-4610.1976.hed1504282.x","article-title":"Treatment of migraine with isometheptene, acetaminophen, and dichloralphenazone combination: a double-blind, crossover trial","volume":"15","author":"Diamond","year":"1976","journal-title":"Headache"},{"issue":"10","key":"10.1002\/14651858.CD008040.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1468-2982.2005.00948.x","article-title":"The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study","volume":"25","author":"Diener","year":"2005","journal-title":"Cephalalgia"},{"issue":"5","key":"10.1002\/14651858.CD008040.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1600-0404.1990.tb00996.x","article-title":"Randomized double-blind comparison of tolfenamic acid and paracetamol in migraine","volume":"81","author":"Larsen","year":"1990","journal-title":"Acta Neurologica Scandinavica"},{"issue":"9","key":"10.1002\/14651858.CD008040.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/jama.1962.03050090045008","article-title":"Classification of headache","volume":"179","year":"1962","journal-title":"JAMA"},{"issue":"8","key":"10.1002\/14651858.CD008040.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1212\/01.wnl.0000323925.29520.e7","article-title":"Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment","volume":"71","author":"Bigal","year":"2008","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD008040.pub2-BIB16|cit16","first-page":"S203","article-title":"Mechanism of action of acetaminophen: is there a cyclooxygenase 3?","volume":"31","author":"Botting","year":"2000","journal-title":"Clinical Infectious Diseases"},{"issue":"21","key":"10.1002\/14651858.CD008040.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"13926","DOI":"10.1073\/pnas.162468699","article-title":"COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic\/antipyretic drugs: cloning, structure and expression","volume":"99","author":"Chandrasekharan","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1002\/14651858.CD008040.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/oxfordjournals.qjmed.a030141","article-title":"Economic and social impact of migraine","volume":"89","author":"Clarke","year":"1996","journal-title":"The Quarterly Journal of Medicine"},{"issue":"6977","key":"10.1002\/14651858.CD008040.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/bmj.310.6977.452","article-title":"The number needed to treat: a clinically useful measure of treatment effect","volume":"310","author":"Cook","year":"1995","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD008040.pub2-BIB20|cit20","first-page":"9","article-title":"Paracetamol and aspirin","volume":"23","year":"1997","journal-title":"Current Problems in Pharmacovigilance"},{"issue":"2","key":"10.1002\/14651858.CD008040.pub2-BIB21|cit21","first-page":"123","article-title":"Treatment of pain or fever with paracetamol (acetaminophen) in the alcoholic patient: a systematic review","volume":"7","author":"Dart","year":"2000","journal-title":"American Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD008040.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1526-4610.2006.00631.x","article-title":"Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study","volume":"47","author":"Diamond","year":"2007","journal-title":"Headache"},{"issue":"5","key":"10.1002\/14651858.CD008040.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2165\/00003495-199856050-00006","article-title":"A practical guide to the management and prevention of migraine","volume":"56","author":"Diener","year":"1998","journal-title":"Drugs"},{"issue":"2","key":"10.1002\/14651858.CD008040.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1017\/S0317167100047697","article-title":"Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey","volume":"20","author":"Edmeads","year":"1993","journal-title":"Canadian Journal of Neurological Sciences"},{"issue":"9","key":"10.1002\/14651858.CD008040.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1468-1331.2009.02748.x","article-title":"EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force","volume":"16","author":"Evers","year":"2009","journal-title":"European Journal of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD008040.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2165\/00019053-199813060-00003","article-title":"The economic burden of migraine to society","volume":"13","author":"Ferrari","year":"1998","journal-title":"Pharmacoeconomics"},{"issue":"5381","key":"10.1002\/14651858.CD008040.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/240410a0","article-title":"Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol)","volume":"240","author":"Flower","year":"1972","journal-title":"Nature"},{"issue":"3","key":"10.1002\/14651858.CD008040.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1212\/01.WNL.0000150904.28131.DD","article-title":"A trial of metoclopramide vs sumatriptan for the emergency department treatment of migraines","volume":"64","author":"Friedman","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD008040.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00045391-200501000-00008","article-title":"Mechanism of action of paracetamol","volume":"12","author":"Graham","year":"2005","journal-title":"American Journal of Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD008040.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/jech.51.2.175","article-title":"Use of paracetamol for suicide and non-fatal poisoning in the UK and France: are restrictions on availability justified?","volume":"51","author":"Gunnell","year":"1997","journal-title":"Journal of Epidemiology and Community Health"},{"issue":"6","key":"10.1002\/14651858.CD008040.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2165\/00002018-200730060-00002","article-title":"Impact of restricting paracetamol pack sizes on paracetamol poisoning in the United Kingdom: a review of the literature","volume":"30","author":"Hawkins","year":"2007","journal-title":"Drug Safety"},{"issue":"7296","key":"10.1002\/14651858.CD008040.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1136\/bmj.322.7296.1203","article-title":"Effects of legislation restricting pack sizes of paracetamol and salicylate on self poisoning in the United Kingdom: before and after study","volume":"322","author":"Hawton","year":"2001","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD008040.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1524-4733.2008.00404.x","article-title":"The burden of migraine in the United States: current and emerging perspectives on disease management and economic analysis","volume":"12","author":"Hazard","year":"2009","journal-title":"Value in Health"},{"issue":"2","key":"10.1002\/14651858.CD008040.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1096\/fj.07-8506com","article-title":"Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man","volume":"22","author":"Hinz","year":"2008","journal-title":"Federation of American Societies for Experimental Biology Journal"},{"issue":"8","key":"10.1002\/14651858.CD008040.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archinte.159.8.813","article-title":"Burden of migraine in the United States:disability and economic costs","volume":"159","author":"Hu","year":"1999","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD008040.pub2-BIB36|cit36","first-page":"1","article-title":"Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain","volume":"8 Suppl 7","year":"1988","journal-title":"Cephalalgia"},{"issue":"9","key":"10.1002\/14651858.CD008040.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1046\/j.1468-2982.2000.00117.x","article-title":"Guidelines for controlled trials of drugs in migraine: second edition","volume":"20","year":"2000","journal-title":"Cephalalgia"},{"key":"10.1002\/14651858.CD008040.pub2-BIB38|cit38","first-page":"1","article-title":"The International Classification of Headache Disorders: 2nd edition","volume":"24 Suppl 1","year":"2004","journal-title":"Cephalalgia"},{"issue":"2-3","key":"10.1002\/14651858.CD008040.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0304-3959(96)03033-3","article-title":"Developing a database of published reports of randomised clinical trials in pain research","volume":"66","author":"Jadad","year":"1996","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD008040.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"issue":"1","key":"10.1002\/14651858.CD008040.pub2-BIB41|cit41","first-page":"36","article-title":"Improvements in health-related quality of life with sumatriptan treatment for migraine","volume":"42","author":"Jhingran","year":"1996","journal-title":"Journal of Family Practice"},{"issue":"2","key":"10.1002\/14651858.CD008040.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/0003-4819-107-2-224","article-title":"Meta-analysis in clinical research","volume":"107","author":"L'Abb\u00e9","year":"1987","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD008040.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1111\/j.1526-4610.1999.00006.x","article-title":"Acute migraine therapy: do doctors understand what patients with migraine want from therapy?","volume":"39 Suppl 2","author":"Lipton","year":"1999","journal-title":"Headache"},{"issue":"5","key":"10.1002\/14651858.CD008040.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","article-title":"Migraine prevalence, disease burden, and the need for preventive therapy","volume":"68","author":"Lipton","year":"2007","journal-title":"Neurology"},{"issue":"8","key":"10.1002\/14651858.CD008040.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archinte.159.8.857","article-title":"Changes in resource use and outcomes for patients with migraine treated with sumatriptan: a managed care perspective","volume":"159","author":"Lofland","year":"1999","journal-title":"Archives of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD008040.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1526-4610.2006.00430.x","article-title":"Recognition and therapeutic management of migraine in 2004, in France: results of FRAMIG 3, a French nationwide population-based survey","volume":"46","author":"Lucas","year":"2006","journal-title":"Headache"},{"issue":"3","key":"10.1002\/14651858.CD008040.pub2-BIB47|cit47","first-page":"84","article-title":"The prevalence and characteristics of migraine among the Belgian working population","volume":"107","author":"Moens","year":"2007","journal-title":"Acta Neurologica Belgica"},{"issue":"3","key":"10.1002\/14651858.CD008040.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0304-3959(98)00140-7","article-title":"Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects","volume":"78","author":"Moore","year":"1998","journal-title":"Pain"},{"key":"10.1002\/14651858.CD008040.pub2-BIB49|cit49","first-page":"50","article-title":"Calculating confidence intervals for relative risk, odds ratios and standardised ratios and rates","volume-title":"Statistics with confidence - confidence intervals and statistical guidelines","author":"Morris","year":"1995"},{"issue":"3","key":"10.1002\/14651858.CD008040.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/MOG.0b013e3282f9764b","article-title":"Drug-induced liver injury in 2007","volume":"24","author":"Norris","year":"2008","journal-title":"Current Opinion in Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD008040.pub2-BIB51|cit51","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0304-3959(02)00024-6","article-title":"Pharmacological treatments for acute migraine: quantitative systematic review","volume":"97","author":"Oldman","year":"2002","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD008040.pub2-BIB52|cit52","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1526-4610.1994.hed3406337.x","article-title":"Measuring the functional status and well-being of patients with migraine headache","volume":"34","author":"Osterhaus","year":"1994","journal-title":"Headache"},{"key":"10.1002\/14651858.CD008040.pub2-BIB53|cit53","unstructured":"PharmWeb Paracetamol Information Centre www.pharmweb.net\/pwmirror\/pwy\/paracetamol\/pharmwebpic.html"},{"issue":"2","key":"10.1002\/14651858.CD008040.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00045391-200007020-00007","article-title":"Therapeutic misadventure with paracetamol: fact or fiction?","volume":"7","author":"Prescott","year":"2000","journal-title":"American Journal of Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD008040.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1526-4610.2008.01263.x","article-title":"Prevalence and burden of headache and migraine in Germany","volume":"49","author":"Radtke","year":"2009","journal-title":"Headache"},{"issue":"6","key":"10.1002\/14651858.CD008040.pub2-BIB56|cit56","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/BF00607087","article-title":"Aspirin pharmacokinetics in migraine. The effect of metoclopramide","volume":"24","author":"Ross-Lee","year":"1983","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"10","key":"10.1002\/14651858.CD008040.pub2-BIB57|cit57","first-page":"506","article-title":"Metoclopramide as a painkiller for intense migraine headache in emergency departments","volume":"47","author":"Salazar-Tortolero","year":"2008","journal-title":"Revista de Neurologia"},{"issue":"9362","key":"10.1002\/14651858.CD008040.pub2-BIB58|cit58","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0140-6736(03)12841-3","article-title":"COX-3: just another COX or the solitary elusive target of paracetamol?","volume":"361","author":"Schwab","year":"2003","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008040.pub2-BIB59|cit59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00019053-199700111-00003","article-title":"Burden of migraine. A review of its socioeconomic impact","volume":"11 Suppl 1","author":"Solomon","year":"1997","journal-title":"Pharmacoeconomics"},{"issue":"18","key":"10.1002\/14651858.CD008040.pub2-BIB60|cit60","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1055\/s-2008-1067713","article-title":"Diagnosis of migraine","volume":"113","author":"Soyka","year":"1988","journal-title":"Deutsche Medizinische Wochenschrift"},{"issue":"7109","key":"10.1002\/14651858.CD008040.pub2-BIB61|cit61","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/bmj.315.7109.635","article-title":"Impact of covert duplicate results on meta-analysis: a case study","volume":"315","author":"Tram\u00e8r","year":"1997","journal-title":"BMJ"},{"issue":"5939","key":"10.1002\/14651858.CD008040.pub2-BIB62|cit62","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/bmj.4.5939.265","article-title":"Absorption of effervescent aspirin during migraine","volume":"4","author":"Volans","year":"1974","journal-title":"British Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD008040.pub2-BIB63|cit63","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2125.1975.tb00472.x","article-title":"The effect of metoclopramide on the absorption of effervescent aspirin in migraine","volume":"2","author":"Volans","year":"1975","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"4","key":"10.1002\/14651858.CD008040.pub2-BIB64|cit64","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1592\/phco.23.4.494.32124","article-title":"Over-the-counter drugs for acute migraine attacks: literature review and recommendations","volume":"23","author":"Wenzel","year":"2003","journal-title":"Pharmacotherapy"}],"updated-by":[{"DOI":"10.1002\/14651858.cd008040.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,4,30]],"date-time":"2013-04-30T00:00:00Z","timestamp":1367280000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD008040.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T08:01:13Z","timestamp":1740643273000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD008040.pub2"}},"subtitle":[],"editor":[{"given":"Maura","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2010,11,10]]},"references-count":64,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008040.pub2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.6279956.6358054","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2010,11,10]]}}}